hy·per·ar·gi·ni·ne·mi·a

(hī'pĕr-ar'ji-ni-nē'mē-a),

Elevated levels of arginine in the blood plasma; usually associated with a deficiency of arginase.

Farlex Partner Medical Dictionary © Farlex 2012

Mentioned in

arginase deficiency

References in periodicals archive

Aeglea is developing pegzilarginase for the treatment of patients with Arginase 1 Deficiency, a rare debilitating disease of arginine metabolism presenting in childhood with persistent hyperargininemia, severe progressive neurological abnormalities and early mortality.

Aeglea BioTherapeutics to Present New 20-Dose Data for Pegzilarginase in Patients with Arginase 1 Deficiency at 2019 SSIEM Symposium

Aeglea is developing pegzilarginase for the treatment of patients with Arginase 1 Deficiency, a rare debilitating disease presenting in childhood with persistent hyperargininemia, severe progressive neurological abnormalities and early mortality.

Aeglea BioTherapeutics Reports Second Quarter 2019 Financial Results and Corporate Highlights

All content on this website, including dictionary, thesaurus, literature, geography, and other reference data is for informational purposes only. This information should not be considered complete, up to date, and is not intended to be used in place of a visit, consultation, or advice of a legal, medical, or any other professional.